l General Information |
Product Name | Solifenacin succinate |
General description | Solifenacin succinate is a quinuclidine and tetrahydroisoquinoline derivative and selective M3 muscarinic agonist. |
Synonym | [(3R)-1-azabicyclo[2.2.2]octan-3-yl] (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate; butanedioic acid; Vesicare; Vesikur |
Purity | ≥98%(HPLC) | CAS Number | 242478-38-2 |
Formula | C27H32N2O6 | Molecular Weight | 480.561 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White or light yellow solid |
Solubility(25℃) | DMSO | ~3mg/mL |
Ethanol | ~5mg/mL |
Water | ≥50mg/mL |
l Biological Information |
Biochem/Physiol Actions | Solifenacin is a competitive muscarinic receptor antagonist. Muscarinic receptors play an important role in several major cholinergically mediated functions, including contractions of urinary bladder smooth muscle and stimulation of salivary secretion. |
Application | 1. Urological Agents 2. Muscarinic Antagonists |
l Packaging & Storage |
Packaging | 25mg; 100mg; 250mg; |
Storage temp. | 0-5℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
